Records containing: Pulmonary Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2014-08-13Detection of Mycobacteria in Lungs and Culture Using an Ultra-fast Gas Chromatograph
-
CLINICAL_TRIALS study record update · 2014-06-23Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis (EVIDENT Study): a Randomized, Double Blind, Controlled Trial
-
CLINICAL_TRIALS study record update · 2014-05-08TBTC Study 29: Evaluation of a Rifapentine-containing Regimen for Intensive Phase Treatment of Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2014-02-24A Phase 2a, Randomized, 2-Arm, Open-Label, Clinical Trial of the Efficacy of Linezolid Combined With Antituberculous Therapy in Subjects With Extensively Drug-Resistant (XDR) Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2013-02-28Relationship Between TLR2 Polymorphism and Pulmonary Tuberculosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-10-18ClinicalTrials.gov study NCT00298870
-
CLINICAL_TRIALS study record update · 2012-07-06A Double Blind, Randomized, Parallel, Placebo Control Design Study to Determine the Effect of Addition of Vitamin D to Conventional Anti TB Therapy
-
CLINICAL_TRIALS study record update · 2012-06-14Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2012-01-02Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease in Populations of High vs. Low Tuberculosis Endemicity
-
CLINICAL_TRIALS study record update · 2011-04-12A Single-Center, Open-Label, Randomized, Crossover Design Study to Evaluate the Effect of Dietary Status on Pharmacokinetic Profile of Orally Administered First-Line Anti-TB Drugs in Subjects With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2011-02-28A Double-blind, Multicentre, Parallel Group, Randomised, Controlled Trial to Evaluate the Possible Benefit of Isoniazid Dose Adjustment According to the Genotype for NAT2 (Arylamine N-acetyltransferase Type 2) in Patients With Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2010-11-17Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis: Randomized Placebo Controlled Trial
-
CLINICAL_TRIALS study record update · 2010-11-03The Impact Factor Analysis of the Therapeutic Drug Monitoring of Oral 2nd Line Antituberculosis Agent, Cycloserine
-
CLINICAL_TRIALS study record update · 2009-09-15Efficacy of Oral Zinc Administration as an Adjunct Therapy in Category I Pulmonary Tuberculosis Along With Assessment of Immunological Parameters (Double-blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial
-
CLINICAL_TRIALS study record update · 2009-02-03Prospective Study of N-acetyltransferase2 (NAT2) Gene and Rifampicin Induced Cytochrome P-450 as Susceptible Risk Factors for Antituberculosis Drug Induced Hepatitis
-
CLINICAL_TRIALS study record update · 2008-12-05Community Health Workers Improve Tuberculosis Case Notification and Treatment Success in Southern Ethiopia
-
CLINICAL_TRIALS study record update · 2008-03-04Treatment of Multiply Drug Resistant Tuberculosis With Interferon Gamma: A Phase I/II Dose Escalation Trial
-
CLINICAL_TRIALS study record update · 2007-09-18Adjunct Vitamin A Therapy for Tuberculosis and HIV/AIDS
-
CLINICAL_TRIALS study record update · 2007-03-07A Phase II Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Four Oral Doses of OPC-67683 in Patients With Uncomplicated, Smear-Positive, Pulmonary Tuberculosis